Intralesional steroid therapy of pyoderma gangrenosum.

Treatment of pyoderma gangrenosum complicating ulcerative colitis has in the past been frustrating and usually unsuccessful, frequently resulting in colectomy. Intralesional steroid therapy has been used off and on in a few patients, but the treatment is not widely known to gastroenterologists. We report two patients successfully treated for early pyoderma gangrenosum by intralesional injection of triamcinolone acetonide (Kenalog, 40 mg injection) together with conventional doses of systemic steroids. A single series of injections was sufficient to bring about healing of the lesions in both patients. The treatment permitted early discharge of patients from the hospital, and the skin lesions were completely healed within 2 months. The lesions have not recurred in follow-up examinations of 11/2 and 21/2 years, respectively. We hope that other physicians will find this approach equally effective.
AuthorsF Goldstein, R Krain, J J Thornton
JournalJournal of clinical gastroenterology (J Clin Gastroenterol) Vol. 7 Issue 6 Pg. 499-501 (Dec 1985) ISSN: 0192-0790 [Print] UNITED STATES
PMID4086744 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Triamcinolone Acetonide
  • Methylprednisolone
  • Adolescent
  • Adult
  • Colitis, Ulcerative (complications)
  • Female
  • Gangrene
  • Humans
  • Injections
  • Methylprednisolone (therapeutic use)
  • Pyoderma (drug therapy, etiology, pathology)
  • Triamcinolone Acetonide (administration & dosage, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: